Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Shravya Balmuri"'
Autor:
Krishna Prasad Bashyal, Sangam Shah, Calvin Ghimire, Shravya Balmuri, Pradip Chaudhary, Sandip Karki, Anuj Krishna Poudel, Ashbina Pokharel, Vishal Devarkonda, Samina Hayat
Publikováno v:
International Journal of Rheumatology, Vol 2024 (2024)
Immune thrombocytopenic purpura (ITP) is an immune-mediated disorder characterized by the destruction of platelets and megakaryocytes due to autoantibodies against the platelet surface proteins. ITP without any apparent cause of thrombocytopenia is d
Externí odkaz:
https://doaj.org/article/ef6ce24b92c946bba40796d8e0c3c0cd
Autor:
Krishna Bashyal, Kamal Dhungana, Deepesh Yadav, Dilli Ram Poudel, Calvin Ghimire, Shravya Balmuri
Publikováno v:
Clinical Case Reports, Vol 11, Iss 6, Pp n/a-n/a (2023)
Abstract Osteitis Condensans Illi (OCI) is an underrecognized cause of low back pain involving iliac bones with relative sparing of sacroiliac joint. We present a case of 48‐year‐old female who was diagnosed as a case of OCI after having back sym
Externí odkaz:
https://doaj.org/article/6d65c00403d249e2a5544eedb09ca293
Autor:
Nischit, Baral, Waiel, Abusnina, Shravya, Balmuri, Amith, Seri, Soumya, Kambalapalli, Prem R, Parajuli, Basel, Abdelazeem, Krishna P, Bashyal, Niranjan, Ojha, Bidhya, Timilsina, Timir K, Paul
Publikováno v:
Journal of Community Hospital Internal Medicine Perspectives. 12:17-24
Patients hospitalized for acute myocardial infarction (AMI) may have concomitant positive coronavirus disease 2019 (COVID-19). We aimed to compare the risk of in-hospital mortality in patients primarily hospitalized for AMI with or without concomitan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99c5ce314530c6f2671e106f6962da46
https://doi.org/10.55729/2000-9666.1103
https://doi.org/10.55729/2000-9666.1103
Publikováno v:
Cureus.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3bcfec0d5d1b99f53d942ec1c82ef150
https://doi.org/10.7759/cureus.39538
https://doi.org/10.7759/cureus.39538
Publikováno v:
Cureus.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d10257146e22ab78f8fe195b37efd96d
https://doi.org/10.7759/cureus.28215
https://doi.org/10.7759/cureus.28215
Autor:
Tejaswi Vinjam, Calvin Ghimire, Nischit Baral, Simi M. Mathew, Shravya Balmuri, Raghavendra Akhil Bogabathina, Joshua Christy, Arvind Kunadi
Publikováno v:
Blood. 140:11351-11351
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::598d8051adf5554bc1889da21f4cf6b3
https://doi.org/10.1182/blood-2022-156846
https://doi.org/10.1182/blood-2022-156846
Publikováno v:
Journal of Clinical Oncology. 40:e19563-e19563
e19563 Background: Tisagenlecleucel is an anti-CD19 chimeric antigen receptor T-cell therapy approved for refractory diffuse large B-cell lymphoma(DLBCL) in May 2018. However, a recently concluded phase 3 international trial showed that Tisagenlecleu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26fe8de4a222b4788190c41e7429bad5
https://doi.org/10.1200/jco.2022.40.16_suppl.e19563
https://doi.org/10.1200/jco.2022.40.16_suppl.e19563